在Mycobacterium结核病感染中的耐药性机制以及疫苗开发中的挑战
Shuying Zhang1, Juan Cheng1, Yuanyuan Tang2
1Department of Laboratory Medicine, Weifang No. 2 People's Hospital, Weifang, China.
Frontiers in pharmacology
|February 25, 2026
概括
耐药结核病 (TB) 由于复杂的抗药机制,构成了全球威胁. 新的疫苗和疗法对于有效控制和消除结核病至关重要.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 公共卫生 公共卫生
背景情况:
- 耐药性Mycobacterium结核病 (Mtb) 是一个主要的全球卫生危机,降低了抗生素的有效性.
- Mtb耐药性涉及复杂的相互作用,包括细胞壁变化,代谢转变和表观遗传调节,有助于免疫逃避.
- 治疗失败,治疗持续时间长,死亡率增加和耐药菌株的传播需要新的策略.
研究的目的:
- 审查Mtb.中多方面的耐药性途径.
- 分析结核疫苗开发方面的挑战和进展.
- 探索针对耐药结核病的新型治疗策略.
主要方法:
- 文献综述综合了有关Mtb耐药机制的信息.
- 对当前疫苗有效性的分析,包括Bacillus Calmette-Guérin (BCG) 和下一代候选疫苗.
- 探索新兴的治疗方法,如新药和宿主导疗法.
主要成果:
- Mtb耐药性是多因素的,涉及与免疫逃避相关的遗传和非遗传因素.
- 像BCG这样的现有疫苗对抗耐药结核病的疗效有限.
- 新型药物 (例如,贝达基林) 和宿主导疗法提供了有前途的替代方案.
结论:
- 多价值疫苗和化学免疫疗法是未来的关键方向.
- 全球数据共享对于消除结核病的努力至关重要.
- 结合新疫苗和治疗方法的综合战略对于对抗耐药结核病至关重要.
更多相关视频
06:26Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
3.1K
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
2.3K
相关概念视频
Defense Against Bacterial Pathogens
3.1K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
3.1K
Development of Antibiotic Resistance
1.7K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.7K
Pulmonary Tuberculosis V
680
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
680
Pulmonary Tuberculosis I
1.1K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
Microorganisms in Medicine and Therapeutics
1.2K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.2K
Pulmonary Tuberculosis II
1.7K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.7K
